GE HealthCare Technologies Inc. (L0T.SG)
| Previous close | 61.00 |
| Open | 62.00 |
| Bid | 63.00 x N/A |
| Ask | 64.50 x N/A |
| Day's range | 62.00 - 62.00 |
| 52-week range | 51.81 - 79.50 |
| Volume | |
| Avg. volume | 123 |
| Market cap | 30.609B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 20.06 |
| EPS (TTM) | 3.09 |
| Earnings date | N/A |
| Forward dividend & yield | 0.11 (0.18%) |
| Ex-dividend date | 19 Oct 2023 |
| 1y target est | N/A |
Business WireGE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023
CHICAGO, November 29, 2023--GE HealthCare is proud to announce the addition of True Enhance DL to its Effortless Recon DL portfolio.
Business WireGE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis
CHICAGO, November 28, 2023--Today GE HealthCare (Nasdaq: GEHC) announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX. The updated PTX algorithm expands Critical Care Suite’s on-device triage capabilities by providing immediate notification of the presence or absence of pneumothorax, as well as an overlay display both on-device and in PACS to assist with PTX localization.
Business WireGE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection
CHICAGO, November 27, 2023--GE HealthCare announces new AI platform to support clinicians with breast cancer detection, improved workflow productivity - MyBreastAI Suite.
